USP14 and gastric cancer: Notably, as shown in Figure 1B, aberrantly increased USP14 expression positively correlated with poor overall survival (OS) of GC patients (logrank P = 0.00012), and in different pathological subtypes (diffuse, logrank P = 0.0023; intestinal, logrank P = 2.8e‐6).11 Together, these in silico study results showed that USP14 may serve as an OS marker for GC patients, implying important roles it may play in GC.